Operationalizing complex, rare neuromuscular clinical trials

Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support

Teilen unserer patientenorientierten Best Practices, die wir auf Grundlage unserer umfassenden Erfahrung mit Alzheimer entwickelt haben.

At Fortrea, we're committed to advancing research in Alzheimer's Disease (AD) and other dementias. Learn about our best practices and recommendations developed from years of experience advancing these complex studies.

Applying a patient- and site-centric approach in an early Phase I Alzheimer’s disease study

This case study discusses how Fortrea applied creative problem-solving to work though inherent challenges and shares a unique enrollment strategy for supporting sites and patients.

Patient Centricity in Neurodegenerative diseases

Enhancing endpoint protection in pain management clinical trials

Key considerations for endpoint protection in pain management clinical trials

Parkinson’s disease: multiple ascending dose

Collaborative communication helped meet sponsor’s milestones and maintain patient safety

Promoting patient and site centricity in neurodegenerative disease clinical trials

Patient-centric practices for AD

Teilen unserer patientenorientierten Best Practices, die wir auf Grundlage unserer umfassenden Erfahrung mit Alzheimer entwickelt haben.

Phase I Alzheimer’s Disease

Applying a patient- and site-centric approach in an early Phase I Alzheimer’s Disease study

Importance of patient perspectives in neurology clinical trials

Incorporating patient perspectives through interviews in neurology clinical trials